On thursday, New Zealand reported its biggest rise in COVID-19 infections in six weeks, all cases detected in Auckland, raising prospects of a further extension of lockdown restrictions in the country's largest city beyond next week. Approx. 1.7 million people in Auckland are under strict quarantine
Dangerous blood clots can occur in moderate COVID-19 A European study has found an elevated risk of a life-threatening blood clot called venous thromboembolism (VTE) in COVID-19 patients who were not critically ill. The blood clot risk had previously been associated with severe COVID-19. The researchers
From the start of the pandemic, researchers, scientists, and antivirus specialists have worked around the clock to find a way to treat COVID-19. Codivir, an innovative new drug from Code Pharma, now appears to have the potential to revolutionize the fight against the virus. In
On Friday the Centers for Disease Control and Prevention said, the United States will accept the use by international visitors of COVID-19 vaccines authorized by U.S. regulators or the World Health Organization. On Sept. 20, the White House announced the United States in November would lift
Researchers have identified an anti-viral gene that impacts the risk of both Alzheimer's disease and severe Covid-19. A team from the University College London (UCL) estimated that one genetic variant of the OAS1 gene increases the risk of Alzheimer's disease by about 3-6 per cent in
According to the sources, Bharat Biotech which has completed the Phase 2/3 trials of Covid-19 vaccine Covaxin for use in children under 18 years of age has submitted the data to the Central Drugs Standard Control Organisation for its verification and subsequent approval for Emergency Use Authorisation
To ensure affected patients get better care, the WHO has come up with a ‘clinical case definition’ of ‘post-Covid condition’, stating that it occurs in individuals with a history of probable or confirmed Sars-CoV-2 infection, usually three months from its onset with symptoms, lasts for
The health ministry on Friday said that Malaysia has granted conditional approval for the COVID-19 vaccine made by Pfizer (PFE.N) and BioNTech (22UAy.DE) to be used as a booster shot. The approval allows the vaccine to be used only on adults aged 18 and above, at least six months after
Health officials in Africa are confident and hopeful that the first-ever malaria vaccine ‘Mosquirix’ approved by the World Health Organisation (WHO) will "dramatically change" the way the continent of 1.3 billion people combats the lethal disease. John Nkengasong Director of Africa Centers for Disease Control and
On Wednesday, The World Health Organization (WHO) said the approved vaccination against malaria should be widely given to African children, potentially marking a major advance against a disease that kills hundreds of thousands of people annually. The WHO recommendation is for RTS,S - or Mosquirix -
